3003.90.01.60 - Antiprotozoals (excluding goods described in subheading note 2 to this chapter) 🖩

This HTS subheading, 3003.90.01.60, specifically classifies antiprotozoal medicaments. These are pharmaceutical preparations containing two or more constituents mixed together for the therapeutic or prophylactic treatment of protozoal infections. Crucially, these goods are not presented in measured doses or in forms or packings for retail sale, differentiating them from finished dosage forms. The exclusion noted in subheading note 2 to this chapter signifies that certain specific types of goods, which might otherwise be considered antiprotozoals, are classified elsewhere.

This category is distinct from its siblings: 3003.90.01.20 (Antivirals) and 3003.90.01.40 (Antifungals). While all fall under the broader umbrella of anti-infective medicaments within heading 3003, this specific subheading is dedicated solely to agents targeting protozoa, such as those causing malaria, amoebiasis, or giardiasis. The sibling category 3003.90.01.80, "Other," would encompass anti-infective medicaments that do not fit into the antiviral, antifungal, or antiprotozoal classifications.

As a leaf node, subheading 3003.90.01.60 does not have further subdivisions. Therefore, classification within this category relies on identifying the antiprotozoal nature of the mixed medicament and ensuring it meets the general conditions for heading 3003, namely that it consists of two or more constituents mixed for therapeutic or prophylactic use and is not put up in measured doses or retail packaging. Practical examples might include bulk mixtures of ingredients intended for veterinary use in combating protozoal diseases, or active pharmaceutical ingredients compounded for further processing into therapeutic agents.